Computed head-to-head · 6 dimensions
BMY vs MDT
Bristol-Myers Squibb Company versus Medtronic plc — yield, safety, growth trend, cost, scale, and tax treatment.
BMY wins 3–0 on our six-dimension comparison, but MDT can still be the better fit depending on your priorities — see each dimension below.
Scorecard at a glance
| Dimension | BMY | MDT | Winner |
|---|---|---|---|
| Yield | 4.06% | 3.51% | BMY wins |
| Dividend safety | 6.8/10 | 6.8/10 | Tie |
| Growth trend | +0.10% vs 5y | +0.48% vs 5y | BMY wins |
| Volatility (beta) | 0.23 | 0.58 | BMY wins |
| Scale | $126.8B | $106.5B | Tie |
| Tax efficiency | Qualified-eligible | Qualified-eligible | Tie |
| Overall | 3 wins | 0 wins | BMY wins |
Dimension by dimension
BMY wins on yield (4.06% vs 3.51%)
On a $10,000 investment that's about $55 more in annual dividend income before taxes — though higher yield often comes with higher risk.
BMY's higher yield (4.06%) looks attractive but investors should weigh whether the extra income compensates for any additional risk versus MDT's 3.51% — especially if the higher yield is driven by covered calls or a falling share price.
Safety scores are too close to call (6.8/10 vs 6.8/10)
Both score within 0.3 points on our 0-10 dividend safety scale — comparable risk profiles on the signals we measure.
BMY shows healthier dividend-vs-price trend
BMY's yield is 0.10% above its 5y average, versus 0.48% for MDT. Lower (or below-average) yield trend often means price appreciation outpaced distributions — a healthier signal.
BMY is less volatile (beta 0.23 vs 0.58)
Lower beta means smaller swings vs the S&P 500 — generally a steadier hold for income investors.
Comparable scale ($126.8B vs $106.5B)
Within 1.5x of each other on market cap / AUM — similar institutional footprint.
Both pay qualified-dividend-eligible distributions
Neither is structurally flagged for ordinary-income tax treatment. Most distributions should qualify for the lower long-term capital gains rate if holding-period requirements are met.
How we compare these
Every comparison on this page is computed from current public data, not written by hand. Yield comes from the most recent dividend distribution annualized over current price. Safety scores combine yield zone, payout ratio, trend vs 5-year average, instrument type, and size — see our methodology for the exact formula. Tax-efficiency flags identify covered-call ETFs, REITs, and mREITs which distribute primarily as ordinary income.
This is educational, not investment advice.Scores reflect a snapshot of public data on the "as of" dates shown on each ticker's safety page. Verify on the issuer's investor relations page or your brokerage before making decisions.
Frequently asked
Which is better for income, BMY or MDT?
BMY wins 3–0 on our six-dimension comparison, but MDT can still be the better fit depending on your priorities — see each dimension below.
BMY vs MDT: which has a higher dividend yield?
BMY yields 4.06% and MDT yields 3.51%. On a $10,000 investment that's about $55 more in annual dividend income before taxes — though higher yield often comes with higher risk.
Is BMY or MDT a safer dividend in 2026?
BMY scores 6.8/10 (Solid) on the Infnits dividend safety scale. MDT scores 6.8/10 (Solid). Both have comparable safety scores.
Which has better dividend growth, BMY or MDT?
BMY's yield is 0.10% above its 5y average, versus 0.48% for MDT. Lower (or below-average) yield trend often means price appreciation outpaced distributions — a healthier signal.
BMY vs MDT: which is more tax-efficient?
Neither is structurally flagged for ordinary-income tax treatment. Most distributions should qualify for the lower long-term capital gains rate if holding-period requirements are met.
Get emailed when BMY vs MDT data updates.
Already own BMY or MDT? See if the other adds anything.
Connect your brokerage and Infnits checks whether adding BMY to your existing portfolio actually diversifies — or just duplicates exposure (ETF look-through included).
Check overlap with my portfolio →